On September 14, 2023, Aprogen Medicines Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,318 KRW | +1.07% |
|
+2.09% | +37.29% |
05-14 | Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-19 | Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+37.29% | 240M | |
-15.02% | 10.5B | |
+2.17% | 3.06B | |
-24.06% | 2.12B | |
-18.66% | 1.49B | |
+6.18% | 1.09B | |
-22.90% | 738M | |
-44.00% | 731M | |
-2.17% | 633M | |
-4.38% | 487M |
- Stock Market
- Equities
- A007460 Stock
- News Aprogen Medicines Inc.
- Aprogen Medicines Inc. announced that it has received KRW 70 billion in funding